A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,014,349 shares of VRNA stock, worth $36.4 Million. This represents 2.55% of its overall portfolio holdings.

Number of Shares
3,014,349
Previous 3,014,349 -0.0%
Holding current value
$36.4 Million
Previous $59.9 Million 19.07%
% of portfolio
2.55%
Previous 3.69%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$16.3 - $22.09 $1.14 Million - $1.55 Million
70,000 Added 2.38%
3,014,349 $49.1 Million
Q1 2023

May 15, 2023

BUY
$18.06 - $25.27 $2.32 Million - $3.25 Million
128,629 Added 4.57%
2,944,349 $59.1 Million
Q4 2022

Feb 03, 2023

BUY
$9.84 - $26.13 $7.05 Million - $18.7 Million
716,179 Added 34.11%
2,815,720 $73.6 Million
Q3 2022

Nov 14, 2022

BUY
$4.14 - $13.59 $8.69 Million - $28.5 Million
2,099,541 New
2,099,541 $21.5 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $736M
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Frazier Life Sciences Management, L.P. Portfolio

Follow Frazier Life Sciences Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Life Sciences Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Frazier Life Sciences Management, L.P. with notifications on news.